ReachRx vs DART IGSRT
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ReachRx
Access a vast repository of medical knowledge for healthcare professionals. Quickly find answers to complex clinical questions, stay updated on treatments, and retrieve critical drug information. Connect with pharmaceutical representatives for samples and access support.
- Clinical Search for instant answers
- Access top-rated medical sources
- Stay updated on latest treatments
- Retrieve drug dosing and interactions
- Request pharma sales rep meetings
- Secure communication with reps
Read full descriptionHide full description
ReachRx - we provide the world's medical knowledge at your fingertips. Our clinical search is where the country's top healthcare providers get instant answers to their most challenging questions. Access information from top-rated sources to: - Answer patient questions - Stay up to date on the latest treatments - Retrieve dosing, side effects, and interactions - and so much more Features: - Clinical Search: Instant answers to complex clinical questions from high-quality medical sources - Pharma Request: Request a sales rep meeting, product samples, or patient access information - Rep Message: Securely communicate with sales reps, FRMs, and MSLs
DART IGSRT
This app provides evidence-based clinical decision support for treating Non-Melanoma Skin Cancer with Image-Guided Superficial Radiation Therapy. It guides healthcare professionals through a structured assessment of diagnosis, location, tumor features, and patient status to determine treatment appropriateness.
- Step-by-step clinical assessment wizard
- Interactive body maps for precise location identification
- Evidence-based appropriateness ratings
- Clinical rationale and documentation support
- Offline functionality via PWA technology
- Detailed results summary with counseling points
Read full descriptionHide full description
DART AUC: Evidence-Based Clinical Decision Support for Image-Guided Superficial Radiation Therapy The DART AUC app provides comprehensive, evidence-based clinical decision support for determining the appropriateness of Image-Guided Superficial Radiation Therapy (IGSRT) for Non-Melanoma Skin Cancer (NMSC) treatment. STREAMLINED CLINICAL WORKFLOW Our intuitive step-by-step wizard guides healthcare providers through a structured clinical assessment: • Diagnosis Confirmation – Verify pathologically confirmed NMSC (BCC/SCC) • Anatomic Location – Identify precise tumor location using interactive body maps • Tumor Features – Assess size, histology, depth, and clinical characteristics • Patient Status – Evaluate medical history and treatment contraindications • Review & Submit – Generate comprehensive appropriateness assessment EVIDENCE-BASED CRITERIA Built on the DART Appropriate Use Criteria (AUC) Guidelines, the app provides: - Appropriateness ratings (Appropriate, May Be Appropriate, Rarely Appropriate) - Clinical rationale for each determination - Patient counseling considerations - Treatment planning guidance - Documentation support DESIGNED FOR HEALTHCARE PROFESSIONALS • Medical-Grade Interface – Clean, professional design optimized for clinical use • Progress Tracking – Visual progress indicators throughout the workflow • Comprehensive Assessment – Detailed evaluation of all relevant clinical factors • Instant Results – Immediate appropriateness determination with supporting evidence • Mobile & Tablet Optimized – Works seamlessly on all devices KEY FEATURES Interactive Body Maps Select from detailed anatomic diagrams showing head/neck, trunk, upper extremities, and lower extremities with precise location identification. Clinical Criteria Integration Evaluate tumor characteristics including: - Size measurements - Histologic subtypes (nodular, superficial, infiltrative, morpheaform, etc.) - High-risk features - Previous treatment history Patient-Centered Assessment Consider relevant patient factors: - Medical contraindications - Treatment history - Clinical presentation Detailed Results Summary Receive comprehensive output including: - Clear appropriateness rating - Evidence-based clinical rationale - Patient counseling talking points - Treatment considerations Offline Capability Progressive Web App (PWA) technology enables: - Full offline functionality - Install directly to home screen - Fast, app-like performance - Automatic updates PROFESSIONAL USE ONLY This application is intended for use by qualified healthcare professionals including dermatologists, radiation oncologists, Mohs surgeons, and other providers involved in NMSC treatment planning. ABOUT DART AUC The DART Appropriate Use Criteria were developed through evidence-based consensus by leading experts in dermatology and radiation oncology to guide clinical decision-making for Image-Guided Superficial Radiation Therapy. PRIVACY & SECURITY • No patient data is transmitted or stored externally • All assessments are processed locally on your device • HIPAA-compliant design • No personal health information collected REQUIREMENTS • iOS 14.0 or later • Internet connection for initial installation • Offline access after installation Download DART AUC today and enhance your clinical decision-making with evidence-based guidance for Image-Guided Superficial Radiation Therapy for Non-Melanoma Skin Cancer. --- Disclaimer: This app is a clinical decision support tool. Final treatment decisions should be made by qualified healthcare providers based on individual patient circumstances and clinical judgment.
Screenshots
Verdict
The clearest difference is rating: DART IGSRT at 5.0 against ReachRx's 4.1. DART IGSRT also leads on iOS requirement (15.5 vs 17.0). ReachRx's advantage is ratings volume (8 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
DART IGSRT holds the better App Store score, 5.0 against 4.1. That said, the two scores are not equally well evidenced: ReachRx has 8 ratings behind it against 1, so its average is the more settled of the two.
| Parameter | ReachRx | DART IGSRT |
|---|---|---|
| Price | Free | Free |
| Rating | 4.1 (8 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 66.7% of reviews | — |
| Number of ratings | 8 — better | 1 |
| Update frequency | Monthly | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 17.0 | 15.5 — better |
| Further details — not scored | ||
| Size | 37 MB | 10 MB |
| Age rating | 17+ | 17+ |
| Developer | Patrick DePippo | SkinCure Oncology LLC |
Customer experience
ReachRx
DART IGSRT
In-app purchases
ReachRx
No in-app purchases
DART IGSRT
No in-app purchases
Questions
Is ReachRx free?
Is DART IGSRT free?
Which has better reviews, ReachRx or DART IGSRT?
Do ReachRx or DART IGSRT have ads?
Other comparisons















